Generic Drug Patient Education

Generic medications are just as safe and effective as their brand-name counterparts, and often cost less.  As 9 in 10 prescriptions filled are for generics, people may have questions about how they are the same as the name brand medications and why there is a cost...

Overview & Basics

The FDA Office of Generic Drugs follows a rigorous review process to make sure that, compared to the brand-name (or innovator) medications, the proposed generic medications:Contain the same active/key ingredient;Have the same strength;Use the same dosage form (for...

Aytu Biopharma – 716599 – 09/09/2025

Recipient: Recipient Name Josh Disbrow Recipient Title Chief Executive Officer Aytu Biopharma 7900 E. Union Avenue, Suite 920Denver, CO 80237United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING...

FWD Care, Inc. dba FWD – 716696

Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTERSeptember 9, 2025FWD:This letter is to advise you that the United...

Novo Nordisk Inc. – 716495

Recipient: Recipient Name Maziar Mike Doustdar Recipient Title President and Chief Executive Officer Novo Nordisk Inc. 800 Scudders Mill RoadPlainsboro, NJ 08536United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary...

Drug Trials Snapshots: ANDEMBRY

HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “MORE INFO” bar...